Members of the #AscendisPharma U.S. team—Zeinab Choucair, MD, MBA, Christine Kingsbury, Anita Walsh, and Kathy Kulkarni—proudly accepted an Innovation Award from BioNJ, recognizing the 2024 FDA approval of our treatment for adults with #hypoparathyroidism. Thank you for this honor BioNJ! It was a great night connecting with industry leaders and celebrating innovation designed to make a meaningful difference for patients.
